JSM Activity #421

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2003 Program page



Legend: = Applied Session, = Theme Session, = Presenter
Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco
Add To My Program
421 Applied Session Wed, 8/6/03, 2:00 PM - 3:50 PM H-Continental Ballroom 1
Biopharmaceutical Statistical Methods - Contributed - Papers
Biopharmaceutical Section
Chair(s): Bill Wang, Merck & Co., Inc.
     2:05 PM   An Application of Path Analysis in the Design of Clinical TrailsYili Lu, Eli Lilly & Company
     2:20 PM   A General Approach to Improve Inference at Interim: Beyond Point EstimationBrenda L. Gaydos, Eli Lilly & Company
     2:35 PM   Identification of Placebo Responders Among Drug-Treated SubjectsThaddeus Tarpey, Wright State University; Eva Petkova, Columbia University; Ying Chen, Columbia University; Todd Ogden, Columbia University
     2:50 PM   Regression to the Mean in HIV Clinical TrialsMichael L. Nessly, Merck & Co., Inc.; Y. H. Josh Chen, Merck Research Laboratories
     3:05 PM   Statistical Processing of Telemetric Food Intake Data for Preclinical Obesity StudiesDonghui Zhang, Merck & Co., Inc.
     3:20 PM   Causal Effects in Randomized Trials in the Presence of Partial ComplianceTong Guo, Montreal Childrens Hospital; Robert W. Platt, McGill University
     3:35 PM   Inference when the Probability of Treatment is EstimatedMary Redman, University of Washington; Babette Brumback, University of California, Los Angeles
 

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003